Literature DB >> 19892675

New mechanisms of pulmonary fibrosis.

Robert M Strieter1, Borna Mehrad2.   

Abstract

The understanding of the pathogenesis of pulmonary fibrosis continues to evolve. The initial hypothetical model suggested chronic inflammation as the cause of pulmonary fibrosis, whereas a subsequent hypothesis posited epithelial injury and impaired wound repair as the etiology of fibrosis without preceding inflammation. Over the past decade, several concepts have led to refinement of these hypotheses. These include the following: (1) the importance of the integrity of the alveolar-capillary barrier basement membrane (BM) to conserving the architecture of the injured lung; (2) conversely, that the failure of reepithelialization and reendothelialization of this BM results in pathologic fibrosis; (3) transforming growth factor-beta is necessary but not sufficient to the pathologic fibrosis of the lungs; (4) the role of persistent antigens in the pathogenesis of usual interstitial pneumonia; and (5) the contribution of epithelial-to-mesenchymal transformation and bone marrow-derived progenitor cells in the pathogenesis of lung fibrosis. In this review, we will discuss these evolving conceptual mechanisms for the pathogenesis of pulmonary fibrosis relevant to idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892675      PMCID: PMC2773361          DOI: 10.1378/chest.09-0510

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  59 in total

1.  Elastic tissue of normal and emphysematous lungs. A tridimensional histologic study.

Authors:  R R WRIGHT
Journal:  Am J Pathol       Date:  1961-09       Impact factor: 4.307

2.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.

Authors:  P J Sime; Z Xing; F L Graham; K G Csaky; J Gauldie
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

Authors:  Bethany B Moore; Jill E Kolodsick; Victor J Thannickal; Kenneth Cooke; Thomas A Moore; Cory Hogaboam; Carol A Wilke; Galen B Toews
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 4.  Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel.

Authors:  Robert M Strieter
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

5.  Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung.

Authors:  A Hancock; L Armstrong; R Gama; A Millar
Journal:  Am J Respir Cell Mol Biol       Date:  1998-01       Impact factor: 6.914

6.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.

Authors:  Z Zhu; R J Homer; Z Wang; Q Chen; G P Geba; J Wang; Y Zhang; J A Elias
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

7.  Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis.

Authors:  Joëlle Marchal-Sommé; Yurdagul Uzunhan; Sylvain Marchand-Adam; Dominique Valeyre; Vassili Soumelis; Bruno Crestani; Paul Soler
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

8.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.

Authors:  Brigham C Willis; Janice M Liebler; Katherine Luby-Phelps; Andrew G Nicholson; Edward D Crandall; Roland M du Bois; Zea Borok
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

9.  TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).

Authors:  Hidenori Kasai; Jeremy T Allen; Roger M Mason; Takashi Kamimura; Zhi Zhang
Journal:  Respir Res       Date:  2005-06-09

10.  Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis.

Authors:  Amir Abdollahi; Minglun Li; Gong Ping; Christian Plathow; Sophie Domhan; Fabian Kiessling; Leslie B Lee; Gerald McMahon; Hermann-Josef Gröne; Kenneth E Lipson; Peter E Huber
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  102 in total

1.  Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells.

Authors:  M Pacurari; Y Qian; W Fu; D Schwegler-Berry; M Ding; V Castranova; N L Guo
Journal:  J Toxicol Environ Health A       Date:  2012

Review 2.  Investigational approaches to therapies for idiopathic pulmonary fibrosis.

Authors:  Richard H Gomer; Mark L Lupher
Journal:  Expert Opin Investig Drugs       Date:  2010-06       Impact factor: 6.206

3.  Organ-derived coatings on electrospun nanofibers as ex vivo microenvironments.

Authors:  Sara N Fischer; Jed K Johnson; Christopher P Baran; Christie A Newland; Clay B Marsh; John J Lannutti
Journal:  Biomaterials       Date:  2010-09-26       Impact factor: 12.479

4.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

5.  miR-29 is a major regulator of genes associated with pulmonary fibrosis.

Authors:  Leah Cushing; Ping Ping Kuang; Jun Qian; Fengzhi Shao; Junjie Wu; Frederic Little; Victor J Thannickal; Wellington V Cardoso; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

Review 6.  Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

Authors:  Aryeh Fischer; Jörg Distler
Journal:  Clin Rheumatol       Date:  2019-08-19       Impact factor: 2.980

7.  Mechanical ventilation augments bleomycin-induced epithelial-mesenchymal transition through the Src pathway.

Authors:  Li-Fu Li; Yung-Yang Liu; Kuo-Chin Kao; Chen-Te Wu; Chih-Hao Chang; Chen-Yiu Hung; Cheng-Ta Yang
Journal:  Lab Invest       Date:  2014-06-23       Impact factor: 5.662

8.  A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Authors:  Yasmina Bauer; John Tedrow; Simon de Bernard; Magdalena Birker-Robaczewska; Kevin F Gibson; Brenda Juan Guardela; Patrick Hess; Axel Klenk; Kathleen O Lindell; Sylvie Poirey; Bérengère Renault; Markus Rey; Edgar Weber; Oliver Nayler; Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

9.  Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Mary L Biggs; Luc Djoussé; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; Russell P Tracy; Susan J Zieman; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2014-04-25       Impact factor: 4.897

Review 10.  Basement membranes in the cornea and other organs that commonly develop fibrosis.

Authors:  Paramananda Saikia; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Cell Tissue Res       Date:  2018-10-03       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.